We are live on ! Find out more
OM icon

Outset Medical

154 hedge funds and large institutions have $1.16B invested in Outset Medical in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 57 increasing their positions, 51 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

149% more call options, than puts

Call options by funds: $588K | Put options by funds: $236K

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

21% more capital invested

Capital invested by funds: $957M → $1.16B (+$201M)

12% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 51

0.05% more ownership

Funds ownership: 7.13%7.18% (+0.05%)

5% less funds holding

Funds holding: 162154 (-8)

28% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 25

Holders
154
Holders Change
-8
Holders Change %
-4.94%
% of All Funds
2.42%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
18
Increased
57
Reduced
51
Closed
25
Calls
$588K
Puts
$236K
Net Calls
+$352K
Net Calls Change
-$60K
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$161M +$1.8M +5,910 +1%
JP Morgan Chase
2
JP Morgan Chase
New York
$106M -$1.61M -5,285 -2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$104M +$1.68M +5,515 +2%
BlackRock
4
BlackRock
New York
$77.3M +$2.01M +6,582 +3%
T. Rowe Price Investment Management
5
T. Rowe Price Investment Management
Maryland
$69.3M -$2.58M -8,444 -4%
BG
6
Bellevue Group
Switzerland
$68.4M +$4.46M +14,608 +8%
CIP
7
Champlain Investment Partners
Vermont
$42.1M +$1.99M +6,524 +5%
Millennium Management
8
Millennium Management
New York
$41M +$31.4M +102,845 +464%
B
9
Braidwell
Connecticut
$31.9M -$5.98M -19,599 -17%
Ameriprise
10
Ameriprise
Minnesota
$31M +$9.78M +32,072 +51%
State Street
11
State Street
Massachusetts
$30.4M +$1.77M +5,797 +7%
EHI
12
Eagle Health Investments
Connecticut
$26.3M
CWG
13
C WorldWide Group
Denmark
$21.9M
Geode Capital Management
14
Geode Capital Management
Massachusetts
$21.3M +$1.08M +3,553 +6%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$20.7M -$155K -507 -0.8%
PA
16
Perceptive Advisors
New York
$19.7M -$3.8M -12,471 -17%
RI
17
RTW Investments
New York
$17.7M
Jennison Associates
18
Jennison Associates
New York
$16.4M +$2.9M +9,519 +24%
FLAM
19
First Light Asset Management
Minnesota
$13.9M +$13M +42,495 New
Fiera Capital (Canada)
20
Fiera Capital (Canada)
Quebec, Canada
$12.2M -$323K -1,058 -3%
Morgan Stanley
21
Morgan Stanley
New York
$12M +$1.11M +3,629 +11%
PVI
22
Pura Vida Investments
New York
$11.9M -$7.65M -25,071 -41%
Massachusetts Financial Services
23
Massachusetts Financial Services
Massachusetts
$11.2M -$94.5K -310 -0.9%
Federated Hermes
24
Federated Hermes
Pennsylvania
$10.9M +$4.81M +15,767 +90%
NCGI
25
Next Century Growth Investors
Minnesota
$10.4M -$1.4M -4,599 -13%

OM Hedge Fund Activity: Q2 2023 in Review

154 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q2 2023, worth a combined $1.16B — up 21% from $957M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of OM and 18 opened new positions — a net loss of 7 holders — while 51 trimmed existing stakes and 57 added.

The largest buyer was Millennium Management, adding an estimated $31.4M. The largest seller was Pura Vida Investments, cutting an estimated $7.65M.

  • 154 institutional investors held Outset Medical (OM) as of Q2 2023, down from 162 in Q1 2023.
  • Funds reported $1.16B of Outset Medical stock for Q2 2023, up 21% quarter-over-quarter.
  • 18 funds opened new Outset Medical positions in Q2 2023 and 25 closed out, a net change of -7 holders.
  • The largest Outset Medical buyer in Q2 2023 was Millennium Management, an estimated $31.4M added.
  • The largest Outset Medical seller in Q2 2023 was Pura Vida Investments, an estimated $7.65M sold.

Based on aggregated 13F filings for Q2 2023.